FilingSEC EDGAR8-K
Arcturus Therapeutics to Present ARCT-810 Clinical Data at Symposium
· SEC accepted
StageClinical
Filing content
Arcturus Therapeutics will present clinical data for its ARCT-810 mRNA therapy for OTC deficiency at a symposium, with further data and regulatory plans expected later this quarter.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…